MedPath

Biopharma Plasma LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 3:2
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (66.7%)
Phase 4
1 (33.3%)

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Phase 3
Recruiting
Conditions
Primary Immune Thrombocytopenia
Interventions
Drug: Intravenous immunoglobulin (IVIG), 10% solution for infusion
First Posted Date
2022-06-16
Last Posted Date
2022-11-16
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
36
Registration Number
NCT05422365
Locations
🇺🇦

Municipal non-profit enterprise "City Clinical Hospital No. 4" of the Dnipro City Council, Dnipro, Ukraine

🇺🇦

Municipal non-profit enterprise "Khmelnytskyi Regional Hospital" of the Khmelnytskyi Regional Council, Khmelnytskyi, Ukraine

🇺🇦

Municipal Non-Profit Enterprise "Kirovohrad Regional Hospital of the Kirovohrad Regional Council", Kropyvnytskyi, Ukraine

and more 9 locations

Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women

Phase 4
Recruiting
Conditions
Pregnancy Related
Interventions
Drug: Human Anti-D (rh) immunoglobulin
First Posted Date
2022-02-18
Last Posted Date
2024-04-18
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
281
Registration Number
NCT05245734
Locations
🇺🇦

Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council", Cherkasy, Cherkasy Region, Ukraine

🇺🇦

Municipal non-profit enterprise "Maternity hospital" of the Chernihiv city council, Chernihiv, Ukraine

🇺🇦

Municipal non-profit enterprise "Chernivtsi Regional Perinatal Center", Chernivtsi, Ukraine

and more 13 locations

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Phase 3
Completed
Conditions
Pneumonia
Covid19
Interventions
First Posted Date
2020-08-05
Last Posted Date
2020-10-14
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
76
Registration Number
NCT04500067
Locations
🇺🇦

Site 08 - "Central City Clinical Hospital of Ivano-Frankivsk City Council", Ivano-Frankivs'k, Ivano-Frankivs'k Region, Ukraine

🇺🇦

Site 02 - "Bila Tserkva City Hospital №3", Bila Tserkva, Kyiv Region, Ukraine

🇺🇦

Site 03 - "Lviv Regional Infectious Diseases Clinical Hospital", Lviv, Lviv Region, Ukraine

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.